Related Experiment Video
Updated: Aug 10, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 11, 2013
Risk factors for severe respiratory syncytial virus infection in infants
1Hopital Robert Debré, Assistance Publique-Hĵpitaux de Paris, France. yannick.aujard@rdb.ap-hop-paris.fr
Insights
Severe respiratory syncytial virus (RSV) disease poses significant risks to children, particularly those with underlying health conditions or environmental exposures. Prevention through infection control and prophylaxis is crucial for managing this serious illness in high-risk infants and children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Severe respiratory syncytial virus (RSV) disease causes significant illness and death in children, especially infants.
- Risk factors include prematurity, congenital heart disease, immunosuppression, cystic fibrosis, crowding, day-care, and passive smoke exposure.
- Current treatments for severe RSV are limited, highlighting the need for effective management strategies.
Purpose of the Study:
- To review the risks and management of severe respiratory syncytial virus (RSV) disease in children.
- To emphasize the importance of preventive measures for high-risk pediatric populations.
Main Methods:
- This review synthesizes information on RSV disease burden, risk factors, and current management approaches.
- Focuses on identifying effective preventive strategies for vulnerable children.
Main Results:
- Children with specific underlying conditions and environmental exposures face increased risk of severe RSV.
- Hospitalization for severe RSV strains healthcare resources and impacts families.
- No curative treatments currently exist for severe RSV disease.
Conclusions:
- Preventive measures, including infection control and prophylaxis, are the most effective strategies for managing severe RSV in high-risk children.
- Early identification and intervention are critical for reducing morbidity and mortality associated with RSV.
Abstract:
Severe respiratory syncytial virus (RSV) disease is associated with unacceptable morbidity and mortality in children, especially in young children. Underlying conditions including prematurity with or without bronchopulmonary dysplasia, congenital heart disease, immunosuppression or another underlying respiratory condition, such as cystic fibrosis, increase the risk of contracting and developing severe RSV disease. Environmental factors such as crowding, day-care attendance, and exposure to passive smoke can increase the risk of severe RSV disease. Children with severe RSV disease often require intensified medical care, including hospitalization, which places a burden on the child, the family, and the health care system. There are currently no effective curative treatments for severe RSV disease. Preventive measures, such as infection control and prophylaxis, appear to be the best options in the management of RSV disease in these high-risk patients.
Related Concept Videos
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease
Asthma I: Introduction
Pneumonia I: Introduction

